Last reviewed · How we verify
Proquamezine (AMINOPROMAZINE)
Proquamezine (generic name: AMINOPROMAZINE) is a drug. It is currently FDA-approved.
Proquamezine is a small molecule with synonyms including AMINOPROMAZINA, AMINOPROMAZINE, and AMINOPROPAZINE. Its exact mechanism and indications are not specified in the provided information, but it is classified as a small molecule.
At a glance
| Generic name | AMINOPROMAZINE |
|---|---|
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Proquamezine CI brief — competitive landscape report
- Proquamezine updates RSS · CI watch RSS
Frequently asked questions about Proquamezine
What is Proquamezine?
Proquamezine (AMINOPROMAZINE) is a Small molecule drug.
What is the generic name of Proquamezine?
AMINOPROMAZINE is the generic (nonproprietary) name of Proquamezine.
What development phase is Proquamezine in?
Proquamezine is FDA-approved (marketed).
Related
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing